Year archive

Pharnext — 2017 filings

All 70 regulatory filings released by Pharnext (ALPHA) in 2017, sourced directly from the official regulator.

70 Filings

2017 Period

2017 filings (70)

Filing	Released	Lang
Pharnext S.A.: Successful Intermediate Analysis for PLEO-CMT Phase III Clinical Trial in Charcot-Marie-Tooth Disease Type 1A Legal Proceedings Report	2017-11-29	English
Communicated under the obligation to provide permanent information / Other communications Regulatory Filings	2017-11-29	English
Communiqués au titre de l'obligation d'information permanente / Autres communiqués Regulatory Filings	2017-11-29	French
Pharnext To Attend November Investors Conferences Report Publication Announcement	2017-11-02	English
Communiqués au titre de l'obligation d'information permanente / Autres communiqués Investor Presentation	2017-11-02	French
Communicated under the obligation to provide permanent information / Other communications Investor Presentation	2017-11-02	English
Pharnext announces acceptance of late breaking abstract at the 10th Clinical Trials on Alzheimer's Disease (CTAD) Conference Report Publication Announcement	2017-10-30	English
Communiqués au titre de l'obligation d'information permanente / Autres communiqués Regulatory Filings	2017-10-30	French
Communicated under the obligation to provide permanent information / Other communications Regulatory Filings	2017-10-30	English
Pharnext's PLEODRUG(TM) PXT3003 to be Featured at the Upcoming Hereditary Neuropathy Foundation (HNF) Annual Patient-Centered Summit Regulatory Filings	2017-10-26	English
Communicated under the obligation to provide permanent information / Other communications Regulatory Filings	2017-10-26	English
Communiqués au titre de l'obligation d'information permanente / Autres communiqués Investor Presentation	2017-10-26	French
First-Half 2017 Earnings Release H1 2017	2017-10-19	English
Pharnext to Present at 4th International Neurotech Investing and Partnering Conference Regulatory Filings	2017-09-28	English
Communicated under the obligation to provide permanent information / Other communications Report Publication Announcement	2017-09-28	English
Communiqués au titre de l'obligation d'information permanente / Autres communiqués Report Publication Announcement	2017-09-28	French
Pharnext Amends the Protocol of the International Pivotal Phase 3 Trials of PXT3003 for Charcot-Marie-Tooth Disease Type 1A Legal Proceedings Report	2017-09-18	English
Communicated under the obligation to provide permanent information / Activity of the issuer (acquisition, sale, partnerships, etc.) Regulatory Filings	2017-09-18	English
Communiqués au titre de l'obligation d'information permanente / Activité de l'émetteur (acquisitions, cessions, partenariats, …) Regulatory Filings	2017-09-18	French
Pharnext to Present at 7th Annual CEC Capital Summit Regulatory Filings	2017-09-13	English
Communiqués au titre de l'obligation d'information permanente / Activité de l'émetteur (acquisitions, cessions, partenariats, …) Report Publication Announcement	2017-09-13	French
Communicated under the obligation to provide permanent information / Activity of the issuer (acquisition, sale, partnerships, etc.) Report Publication Announcement	2017-09-13	English
Pharnext's PXT3003 Featured at the American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) 2017 Annual Meeting Regulatory Filings	2017-09-07	English
Communicated under the obligation to provide permanent information / Activity of the issuer (acquisition, sale, partnerships, etc.) Regulatory Filings	2017-09-07	English
Communiqués au titre de l'obligation d'information permanente / Activité de l'émetteur (acquisitions, cessions, partenariats, …) Regulatory Filings	2017-09-07	French
Pharnext Announces that the DSMB Recommends Continuing the Ongoing Phase 3 Trial of PXT3003 for Charcot-Marie-Tooth Disease Type 1A Regulatory Filings	2017-09-06	English
Communicated under the obligation to provide permanent information / Activity of the issuer (acquisition, sale, partnerships, etc.) Regulatory Filings	2017-09-06	English
Communiqués au titre de l'obligation d'information permanente / Activité de l'émetteur (acquisitions, cessions, partenariats, …) Regulatory Filings	2017-09-06	French
Pharnext to Present at Rodman & Renshaw 19th Annual Global Investment Conference Regulatory Filings	2017-09-05	English
Communicated under the obligation to provide permanent information / Activity of the issuer (acquisition, sale, partnerships, etc.) Report Publication Announcement	2017-09-05	English
Communiqués au titre de l'obligation d'information permanente / Activité de l'émetteur (acquisitions, cessions, partenariats, …) Report Publication Announcement	2017-09-05	French
Communicated under the obligation to provide permanent information / Activity of the issuer (acquisition, sale, partnerships, etc.) Regulatory Filings	2017-08-31	English
Communiqués au titre de l'obligation d'information permanente / Activité de l'émetteur (acquisitions, cessions, partenariats, …) Regulatory Filings	2017-08-31	French
Pharnext to Present PXT864 Data at the Alzheimer's Association International Conference 2017 Environmental & Social Information	2017-07-10	English
Communiqués au titre de l'obligation d'information permanente / Activité de l'émetteur (acquisitions, cessions, partenariats, …) Regulatory Filings	2017-07-10	French
Communicated under the obligation to provide permanent information / Activity of the issuer (acquisition, sale, partnerships, etc.) Regulatory Filings	2017-07-10	English
Pharnext's PLEODRUG(TM), PXT3003, to be Featured in Multiple Presentations at the 2017 Peripheral Nerve Society Meeting Regulatory Filings	2017-06-27	English
Communicated under the obligation to provide permanent information / Other communications Regulatory Filings	2017-06-27	English
Communiqués au titre de l'obligation d'information permanente / Autres communiqués Regulatory Filings	2017-06-27	French
Pharnext to Showcase Pioneering PLEOTHERAPY(TM) R&D Platform at 6th Annual Drug Repositioning, Repurposing and Rescue Conference Regulatory Filings	2017-06-20	English
Communicated under the obligation to provide permanent information / Activity of the issuer (acquisition, sale, partnerships, etc.) Regulatory Filings	2017-06-20	English
Communiqués au titre de l'obligation d'information permanente / Activité de l'émetteur (acquisitions, cessions, partenariats, …) Regulatory Filings	2017-06-20	French
Pharnext Announces Strategic Partnership with Tasly, a Leading Chinese Pharmaceutical Group M&A Activity	2017-05-10	English
Communicated under the obligation to provide permanent information / Other communications Capital/Financing Update	2017-05-10	English
Communiqués au titre de l'obligation d'information permanente / Autres communiqués Capital/Financing Update	2017-05-10	French
Rapport financier annuel Annual Report FY 2016	2017-04-26	French
Pharnext Reports Year End 2016 Financial Results Earnings Release FY 2016	2017-04-26	English
Communiqués au titre de l'obligation d'information permanente / Autres communiqués Share Issue/Capital Change	2017-04-11	French
Pharnext gibt Umplatzierung von Aktien ihres Altaktionars bekannt und starkt damit die Position von Kernaktionaren Share Issue/Capital Change	2017-03-29	German
Information relating to the total number of voting rights and shares making up the capital Major Shareholding Notification	2017-03-29	English
Information relative au nombre total de droits de vote et d'actions composant le capital Major Shareholding Notification	2017-03-29	French
Pharnext to Present New PXT864 Synergy Data at AD/PDTM 2017, the 13th International Conference on Alzheimer's and Parkinson's Diseases and Related Neurological Disorders Regulatory Filings	2017-03-29	English
Communicated under the obligation to provide permanent information / Activity of the issuer (acquisition, sale, partnerships, etc.) Regulatory Filings	2017-03-29	English
Communiqués au titre de l'obligation d'information permanente / Activité de l'émetteur (acquisitions, cessions, partenariats, …) Regulatory Filings	2017-03-29	French
Pharnext Announces Initiation of Phase 3 Extension Study PLEO-CMT-FU of PXT3003 for Treatment of Charcot-Marie-Tooth Disease Type 1A Legal Proceedings Report	2017-03-16	English
Communicated under the obligation to provide permanent information / Other communications Regulatory Filings	2017-03-16	English
Communiqués au titre de l'obligation d'information permanente / Autres communiqués Regulatory Filings	2017-03-16	French
Pharnext gibt Forschungs- und Entwicklungsvereinbarung mit Galapagos zum Aufbau einer neuen Pipeline synergistischer Wirkstoffkombinationen bekannt Regulatory Filings	2017-03-09	German
Communicated under the obligation to provide permanent information / Activity of the issuer (acquisition, sale, partnerships, etc.) Regulatory Filings	2017-03-09	English
Communiqués au titre de l'obligation d'information permanente / Activité de l'émetteur (acquisitions, cessions, partenariats, …) Regulatory Filings	2017-03-09	French
Communiqués au titre de l'obligation d'information permanente / Activité de l'émetteur (acquisitions, cessions, partenariats, …) Report Publication Announcement	2017-02-07	French
Communicated under the obligation to provide permanent information / Activity of the issuer (acquisition, sale, partnerships, etc.) Investor Presentation	2017-02-07	English
Communiqués au titre de l'obligation d'information permanente / Activité de l'émetteur (acquisitions, cessions, partenariats, …) Regulatory Filings	2017-02-02	French
Communicated under the obligation to provide permanent information / Activity of the issuer (acquisition, sale, partnerships, etc.) Regulatory Filings	2017-02-02	English
Communicated under the obligation to provide permanent information / Activity of the issuer (acquisition, sale, partnerships, etc.) Regulatory Filings	2017-01-17	English
Communiqués au titre de l'obligation d'information permanente / Activité de l'émetteur (acquisitions, cessions, partenariats, …) Regulatory Filings	2017-01-17	French
Communicated under the obligation to provide permanent information / Activity of the issuer (acquisition, sale, partnerships, etc.) Report Publication Announcement	2017-01-04	English
Communiqués au titre de l'obligation d'information permanente / Activité de l'émetteur (acquisitions, cessions, partenariats, …) Report Publication Announcement	2017-01-04	French
Share buybacks / Liquidity contracts Information related to liquidity contracts Capital/Financing Update	2017-01-03	English
Rachat d'actions / Contrat de liquidité Information relative au contrat de liquidité Capital/Financing Update	2017-01-03	French

Filings by year

2024 34 filings
2023 106 filings
2022 50 filings
2021 38 filings
2020 14 filings
2019 20 filings
2018 28 filings
2017 70 filings
2016 22 filings